Top

Published in:

01-09-2019 | Gestational Diabetes | Meta-Analysis

Prevalence of gestational diabetes mellitus in Eastern Mediterranean region: a systematic review and meta-analysis

Authors: Mahin Badakhsh, Fereshteh Daneshi, Mahnaz Abavisani, Hosien Rafiemanesh, Salehoddin Bouya, Mahmood Sheyback, Khadije Rezaie Keikhaie, Abbas Balouchi

Published in: Endocrine | Issue 3/2019

Abstract

Purpose

Gestational diabetes mellitus (GDM) is one of the costly challenges in the health field. Despite the individual studies in the Eastern Mediterranean, there is no comprehensive study in this regard. The aim of this study was to determine the prevalence of GDM in the Eastern Mediterranean region.

Methods

In this meta-analysis and systematic review, three international databases (PubMed, Web of science and Scopus) were searched from inception until 30 December 2018. The Hui tool was used to assess the quality of the included studies.

Results

Thirty-three studies performed on 887166 participants were included in the meta-analysis. Based on the results of random effect method, the overall prevalence of GDM was 11.7%. Between six country with have three or more study, pooled prevalence for Saudi Arabi it was 3.6 times more than Israel (17.6 vs. 4.9%), and for Pakistan, Qatar, Bahrain and Iran were 15.3%, 14.7%, 12.2%, and 8.6%, respectively.

Conclusion

Despite the high diversity of methods, the results of the present study indicate a high prevalence of GDM in the Eastern Mediterranean region, indicating more policymakers’ interest in timely screening and proper management.

Available only for authorised users

M. Meregaglia, L. Dainelli, H. Banks, C. Benedetto, P. Detzel, G. Fattore, The short-term economic burden of gestational diabetes mellitus in Italy. BMC Pregnancy Childbirth 18, 58 (2018)CrossRefPubMedPubMedCentral

C. Bommer, V. Sagalova, E. Heesemann, J. Manne-Goehler, R. Atun, T. Bärnighausen et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care 41, 963–970 (2018)CrossRefPubMed

E. Chiefari, B. Arcidiacono, D. Foti, A. Brunetti, Gestational diabetes mellitus: an updated overview. J. Endocrinol. Investig. 40, 899–909 (2017)CrossRef

N. Cho, J. Shaw, S. Karuranga, Y. Huang, J. da Rocha Fernandes, A. Ohlrogge et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 138, 271–281 (2018)CrossRefPubMed

A. Jiwani, E. Marseille, N. Lohse, P. Damm, M. Hod, J.G. Kahn, Gestational diabetes mellitus: results from a survey of country prevalence and practices. J. Matern.-Fetal Neonatal Med. 25, 600–610 (2012)CrossRefPubMed

K.W. Lee, S.M. Ching, V. Ramachandran, A. Yee, F.K. Hoo, Y.C. Chia et al. Prevalence and risk factors of gestational diabetes mellitus in Asia: a systematic review and meta-analysis. BMC Pregnancy Childbirth 18, 494 (2018)CrossRefPubMedPubMedCentral

L. Hartling, D.M. Dryden, A. Guthrie, M. Muise, B. Vandermeer, W.M. Aktary et al. Screening and diagnosing gestational diabetes mellitus. Evid. Rep./Technol. Assess. 210, 1 (2012)

E.M. Wendland, M.R. Torloni, M. Falavigna, J. Trujillo, M.A. Dode, M.A. Campos et al. Gestational diabetes and pregnancy outcomes-a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth 12, 23 (2012)CrossRefPubMedPubMedCentral

D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, P. Group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6, e1000097 (2009)CrossRefPubMedPubMedCentral

10.

J. McGowan, M. Sampson, D.M. Salzwedel, E. Cogo, V. Foerster, C. Lefebvre, PRESS peer review of electronic search strategies: 2015 guideline statement. J. Clin. Epidemiol. 75, 40–46 (2016)CrossRefPubMed

11.

WHO. Projections of mortality and causes of death 2016 to 2060. 2019. https://www.who.int/healthinfo/global_burden_disease/projections/en/

12.

Y. Zhu, C. Zhang, Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr. Diabetes Rep. 16, 7 (2016)CrossRef

13.

T. Tamayo, M. Tamayo, W. Rathmann, P. Potthoff, Prevalence of gestational diabetes and risk of complications before and after initiation of a general systematic two-step screening strategy in Germany (2012–2014). Diabetes Res. Clin. Pract. 115, 1–8 (2016)CrossRefPubMed

14.

S.S. Casagrande, B. Linder, C.C. Cowie, Prevalence of gestational diabetes and subsequent Type 2 diabetes among US women. Diabetes Res. Clin. Pract. 141, 200–208 (2018)CrossRefPubMed

15.

C. Gao, X. Sun, L. Lu, F. Liu, J. Yuan, Prevalence of gestational diabetes mellitus in mainland China: a systematic review and meta‐analysis. J. Diabetes Investig. 10, 154–162 (2019)CrossRefPubMed

16.

K.T. Li, S. Naik, M. Alexander, J.S. Mathad, Screening and diagnosis of gestational diabetes in India: a systematic review and meta-analysis. Acta Diabetol. 55, 1–13 (2018).

17.

S. Macaulay, D.B. Dunger, S.A. Norris, Gestational diabetes mellitus in Africa: a systematic review. PLoS ONE 9, e97871 (2014)CrossRefPubMedPubMedCentral

18.

M. Makgoba, M. Savvidou, P. Steer, An analysis of the interrelationship between maternal age, body mass index and racial origin in the development of gestational diabetes mellitus. BJOG: Int. J. Obstet. Gynaecol. 119, 276–282 (2012)CrossRef

19.

N. Schwartz, Z. Nachum, M.S. Green, The prevalence of gestational diabetes mellitus recurrence—effect of ethnicity and parity: a metaanalysis. Am. J. Obstet. Gynecol. 213, 310–317 (2015)CrossRefPubMed

20.

E.M. Alfadhli, E.N. Osman, T.H. Basri, N.S. Mansuri, M.H. Youssef, S.A. Assaaedi et al. Gestational diabetes among Saudi women: prevalence, risk factors and pregnancy outcomes. Ann. Saudi Med. 35, 222–230 (2015)CrossRefPubMedPubMedCentral

21.

E. Alfadhli, Gestational diabetes in Saudi women identified by the International Association of Diabetes and Pregnancy Study Group versus the former American Diabetes Association criteria: a prospective cohort study. Ann. Saudi Med. 35, 428–434 (2015). https://doi.org/10.5144/0256-4947.2015.428 CrossRefPubMedPubMedCentral

22.

M.S. Ardawi, H.A. Nasrat, H.S. Jamal, H.M. Al-Sagaaf, B.E. Mustafa, Screening for gestational diabetes mellitus in pregnant females. Saudi Med. J. 21, 155–160 (2000)PubMed

23.

M. Bashir, M.E. Abdel-Rahman, M. Aboulfotouh, F. Eltaher, K. Omar, I. Babarinsa et al. Prevalence of newly detected diabetes in pregnancy in Qatar, using universal screening. PLoS ONE 13 (2018). https://doi.org/10.1371/journal.pone.0201247

24.

A.O. Abdelmola, M.S. Mahfouz, M.A.M. Gahtani, Y.J. Mouharrq, B.H.O. Hakami, O.I. Daak et al. Gestational diabetes prevalence and risk factors among pregnant women — Jazan Region, Saudi Arabia. Clin. Diabetol. 6, 172–177 (2017). https://doi.org/10.5603/DK.2017.0028 CrossRef

25.

A.T. Abu-Heija, M. Al-Bash, M. Mathew, Mathew M. Gestational and pregestational diabetes mellitus in omani women: comparison of obstetric and perinatal outcomes. Sultan Qaboos Univ. Med. J. 15, e496–e500 (2015). https://doi.org/10.18295/squmj.2015.15.04.009

26.

M.M. Agarwal, G.S. Dhatt, Y. Othman, Gestational diabetes mellitus prevalence: effect of the laboratory analytical variation. Diabetes Res. Clin. Pract. 109, 493–499 (2015). https://doi.org/10.1016/j.diabres.2015.06.001 CrossRefPubMed

27.

W. Ahsen, B. Meraj, M. Waseem, S. Ahmed, Incidence of gestation diabetes and viral hepatitis in pregnant women. Med. Forum Mon. 25, 81–84 (2014)

28.

S. Al Mahroos, D.S. Nagalla, W. Yousif, H. Sanad, A population-based screening for gestational diabetes mellitus in non-diabetic women in Bahrain. Ann. Saudi Med. 25, 129–133 (2005)CrossRefPubMedPubMedCentral

29.

A.D. Ali, A.A. Mehrass, A.H. Al-Adhroey, A.A. Al-Shammakh, A.A. Amran, Prevalence and risk factors of gestational diabetes mellitus in Yemen. Int. J. Women’s Health 8, 35–41 (2016). https://doi.org/10.2147/ijwh.s97502 CrossRef

30.

A. Ali, A.H. Munir, A. Rafiq, Gestational diabetes in women presenting to teaching hospitals in Khyber Pakhtunkhwa. J. Med. Sci. 26, 14–17 (2018)

31.

M.G. Al-Kuwari, B.S. Al-Kubaisi, Prevalence and predictors of gestational diabetes in Qatar. Diabetol. Croat. 40, 65–70 (2011)

32.

M.A. Al-Rowaily, M.A. Abolfotouh, Predictors of gestational diabetes mellitus in a high-parity community in Saudi Arabia. East. Mediterr. Health J. 16, 636–641 (2010)CrossRefPubMed

33.

A. Bener, N.M. Saleh, A. Al-Hamaq, Prevalence of gestational diabetes and associated maternal and neonatal complications in a fast-developing community: global comparisons. Int. J. Women’s health 3, 367–373 (2011). https://doi.org/10.2147/ijwh.s26094 CrossRef

34.

S. Bibi, U. Saleem, N. Mahsood, The frequency of gestational diabetes mellitus and associated risk factors at khyber teaching hospital Peshawar. J. Post. Med. Inst. 29, 43–46 (2015)

35.

F. Hadaegh, M. Tohidi, H. Harati, M. Kheirandish, S. Rahimi, Prevalence of gestational diabetes mellitus in southern Iran (Bandar Abbas City). Endocr. Pract. 11, 313–318 (2005). https://doi.org/10.4158/ep.11.5.313 CrossRefPubMed

36.

E. Hosseini, M. Janghorbani, A. Aminorroaya, Incidence, risk factors, and pregnancy outcomes of gestational diabetes mellitus using one-step versus two-step diagnostic approaches: a population-based cohort study in Isfahan, Iran. Diabetes Res. Clin. Pract. 140, 288–294 (2018). https://doi.org/10.1016/j.diabres.2018.04.014 CrossRefPubMed

37.

A. Hossein-Nezhad, Z. Maghbooli, A.R. Vassigh, B. Larijani, Prevalence of gestational diabetes mellitus and pregnancy outcomes in Iranian women. Taiwan J. Obstet. Gynecol. 46, 236–241 (2007). https://doi.org/10.1016/s1028-4559(08)60026-1 CrossRefPubMed

38.

M. Keshavarz, N.W. Cheung, G.R. Babaee, H.K. Moghadam, M.E. Ajami, M. Shariati, Gestational diabetes in Iran: incidence, risk factors and pregnancy outcomes. Diabetes Res. Clin. Pract. 69, 279–286 (2005)CrossRefPubMed

39.

M. Manafi, M.H. Khadem-Ansari, Gestational diabetes mellitus in Iranian women: a rising rate. Acta Endocrinol. 9, 71–78 (2013). https://doi.org/10.4183/aeb.2013.71 CrossRef

40.

F. Mohammadzadeh, S. Eshghinia, M.A. Vakili, The prevalence of gestational diabetes mellitus and its related risk factors in Gorgan, north of Iran. Selective or universal screening test is cost-effective? Int. J. Diabetes Dev. Ctries. 35, 225–229 (2015). https://doi.org/10.1007/s13410-014-0209-8 CrossRef

41.

F. Momenzadeh, S.S. Mokhlesi, S. Mohebbi, L.M. Banaem, Gestational diabetes and its risk factors for pregnant women in Tehran Int. J. Trop. Med. 10, 30–33 (2014). https://doi.org/10.3923/ijtmed.2015.30.33 CrossRef

42.

K.E. Rajab, A.A. Issa, Z.A. Hasan, E. Rajab, A.A. Jaradat, Incidence of gestational diabetes mellitus in Bahrain from 2002 to 2010. Int. J. Gynaecol. Obstet.: Off. Organ Int. Fed. Gynaecol. Obstet. 117, 74–77 (2012). https://doi.org/10.1016/j.ijgo.2011.11.013 CrossRef

43.

K.E. Rajab, J.H. Skerman, A.A. Issa, Screening for gestational diabetes by measuring fasting plasma glucose levels. J. Sci. Res. Med. Sci. 5, 5–8 (2003)PubMedPubMedCentral

44.

M. Riaz, A. Nawaz, S.N. Masood, A. Fawwad, A. Basit,A.S. Shera, Frequency of gestational diabetes mellitus using DIPSI criteria, a study from Pakistan. Clin. Epidemiol. Glob. Health (2018). https://doi.org/10.1016/j.cegh.2018.06.003.

45.

T. Sella, V. Shalev, U. Elchalal, A. Chovel-Sella, G. Chodick, Screening for gestational diabetes in the 21st century: a population-based cohort study in Israel. J. Matern.-Fetal Neonatal Med. 26, 412–416 (2013). https://doi.org/10.3109/14767058.2012.733761 CrossRefPubMed

46.

T. Sella, G. Chodick, M. Barchana, A.D. Heymann, A. Porath, E. Kokia et al. Gestational diabetes and risk of incident primary cancer: a large historical cohort study in Israel. Cancer Causes Control 22, 1513–1520 (2011). https://doi.org/10.1007/s10552-011-9825-5 CrossRefPubMed

47.

H. Shahbazian, S. Nouhjah, N. Shahbazian, S. Jahanfar, S.M. Latifi, A. Aleali et al. Gestational diabetes mellitus in an Iranian pregnant population using IADPSG criteria: incidence, contributing factors and outcomes. Diabetes Metab. Syndr. 10, 242–246 (2016). https://doi.org/10.1016/j.dsx.2016.06.019 CrossRefPubMed

48.

N. Shirazian, R. Emdadi, M. Mahboubi, A. Motevallian, Z. Fazel-Sarjuei, N. Sedighpour et al. Screening for gestational diabetes: usefulness of clinical risk factors. Arch. Gynecol. Obstet. 280, 933–937 (2009). https://doi.org/10.1007/s00404-009-1027-y CrossRefPubMed

49.

S. Soheilykhah, M. Mogibian, S. Rahimi-Saghand, M. Rashidi, S. Soheilykhah, M. Piroz, Incidence of gestational diabetes mellitus in pregnant women. Iran. J. Reprod. Med. 8, 24–28 (2010)

50.

B. Utz, B. Assarag, T. Smekens., H. Ennassiri, T. Lekhal, N.E. Ansari et al., Detection and initial management of gestational diabetes through primary health care services in Morocco: an effectiveness-implementation trial. PLoS ONE 13 (2018). https://doi.org/10.1371/journal.pone.0209322

51.

H. Wahabi, A. Fayed, S. Esmaeil, H. Mamdouh, R. Kotb, Prevalence and complications of pregestational and gestational diabetes in Saudi women: analysis from Riyadh Mother and Baby Cohort Study (RAHMA). BioMed. Res. Int. 2017, 6878263 (2017). https://doi.org/10.1155/2017/6878263 CrossRefPubMedPubMedCentral

52.

H.A. Wahabi, S.A. Esmaeil, A. Fayed, R.A. Alzeidan, Gestational diabetes mellitus: maternal and perinatal outcomes in King Khalid University Hospital, Saudi Arabia. J. Egypt. Public Health Assoc. 88, 104–108 (2013). https://doi.org/10.1097/01.epx.0000430392.57811.20 CrossRefPubMed

53.

O. Zamstein, E. Sheiner, T. Wainstock, D. Landau, A. Walfisch, Maternal gestational diabetes and long-term respiratory related hospitalizations of the offspring. Diabetes Res. Clin. Pract. 140, 200–207 (2018). https://doi.org/10.1016/j.diabres.2018.03.050 CrossRefPubMed

Title: Prevalence of gestational diabetes mellitus in Eastern Mediterranean region: a systematic review and meta-analysis
Authors: Mahin Badakhsh
Fereshteh Daneshi
Mahnaz Abavisani
Hosien Rafiemanesh
Salehoddin Bouya
Mahmood Sheyback
Khadije Rezaie Keikhaie
Abbas Balouchi
Publication date: 01-09-2019
Publisher: Springer US
Keywords: Gestational Diabetes
Gestational Diabetes
Published in: Endocrine / Issue 3/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-019-02026-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2019

Reporting quality of 2014–2018 clinical practice guidelines on diabetes according to the RIGHT checklist

Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome

Early detection of cognitive impairment in patients with insulinoma

Human heart shifts from IGF-1 production to utilization with chronic heart failure

Correction: In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia

Correction to: Human heart shifts from IGF-1 production to utilization with chronic heart failure

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage